NASDAQ:AMGN Long Term Investor Alert: Lawsuit Against Directors of Amgen, Inc. Filed
An investor in shares of Amgen, Inc. (NASDAQ:AMGN) filed a lawsuit against directors of Amgen, Inc over alleged breaches of fiduciary duties in connection certain statements.
View full press release